Autism – Global Clinical Trials Review, 2022
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The autism clinical trial market research report provides an overview and top-line data relating to the clinical trials on autism. The report includes an overview of trial counts and their average enrollment in top countries conducted globally. It also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on the number of ongoing trials).
Autism Clinical Trials Market Segmentation by Regions and Countries
The top regions in the autism clinical trials market are Asia Pacific, North America, Europe, the Middle East and Africa, and South and Central America. Most of the clinical trials were conducted in North America.
In the country-wise analysis, The US has the highest number of autism clinical trials, as of January 2022. Canada has the highest average patient enrollment in autism clinical trials, as of January 2022.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the United States has the highest proportion of autism to central nervous system clinical trials as of January 2022.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, China has the highest proportion of autism in central nervous system clinical trials as of January 2022.
Autism Clinical Trials Market Analysis, By Regions
For more regional insights on the autism clinical trials market, download a free report sample
Autism Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the autism clinical trials market are institutions, companies, and the government. Out of them, the institution segment dominates the autism clinical trials market.
Autism Clinical Trials Market Analysis, by Sponsor Types
To know more about key sponsor types in the autism clinical trials market, download a free report sample
Autism Clinical Trials - Competitive Landscape
The leading companies in the autism clinical trials market are Otsuka Holdings Co Ltd, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd, autism Speaks Inc, Johnson & Johnson, Seaside Therapeutics LLC (Inactive), Bristol-Myers Squibb Co, Curemark LLC, Eli Lilly and Co, and Finch Therapeutics Group Inc. Otsuka Holdings Co Ltd sponsored the highest number of autism clinical trials.
Autism Clinical Trials Market Analysis, by Leading Companies
To know more about leading companies in the autism clinical trials market, download a free report sample
Autism Clinical Trials Market Report Overview
Key Regions | Asia Pacific, North America, Europe, The Middle East and Africa, and South and Central America |
Key Countries | The US, Japan, China, Iran, Australia, India, Canada, and The United Kingdom |
Key Sponsor Types | Institution, Company, and The Government |
Leading Companies | Otsuka Holdings Co Ltd, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd, Autism Speaks Inc, Johnson & Johnson, Seaside Therapeutics LLC (Inactive), Bristol-Myers Squibb Co, Curemark LLC, Eli Lilly and Co, and Finch Therapeutics Group Inc |
Scope
The report provides:
- A snapshot of the global clinical trials landscape
- Top-level data related to the clinical trials by region, country, trial status, trial phase, sponsor type, and end-point status
- Reviews of top companies involved and enlists all trials pertaining to the company
- All the unaccomplished trials with the reason for unaccomplishment
- Enrollment trends for the past five years
- Latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd
Autism Speaks Inc
Johnson & Johnson
Seaside Therapeutics LLC (Inactive)
Bristol-Myers Squibb Co
Finch Therapeutics Group Inc
Eli Lilly and Co
Curemark LLC
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key regions in the autism clinical trials market?
The top regions in the autism clinical trials market are Asia Pacific, North America, Europe, the Middle East and Africa, and South and Central America.
-
Which are the key countries in the autism clinical trials market?
The top countries in the autism clinical trials market are the US, Japan, China, Iran, Australia, India, Canada, and the United Kingdom.
-
What are the key sponsor types in the autism clinical trials market?
Institutions, companies, and the government are the key sponsor types in the autism clinical trials market.
-
Which are the leading companies in the autism clinical trials market?
The leading companies in the autism clinical trials market are Otsuka Holdings Co Ltd, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd, Autism Speaks Inc, Johnson & Johnson, Seaside Therapeutics LLC (Inactive), Bristol-Myers Squibb Co, Curemark LLC, Eli Lilly and Co, and Finch Therapeutics Group Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.